Sign inJoin waitlistJoin the waitlist

FS

Federico Sanchez

Hematology & Oncology

Credentials: ·

History

Hematology and Medical Oncology
1984–1987
Internal Medicine
1981–1984
Medical School
1977–1981

Research

Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2…
The Lancet Oncology · 2023 · 214 citations
Phase II study of arsenic trioxide and ascorbic acid for relapsed or refractory lymphoid malignancies: a Wisconsin Oncology Network study
Hematological Oncology · 2009 · 31 citations
Caplacizumab for treatment of thrombotic thrombocytopenic purpura in a patient with anaphylaxis to fresh-frozen plasma
Case report · Transfusion · 2020 · 20 citations

AK
Adel Kardosh
2 papers
AC
Andrea Cercek
2 papers
Andrew Coveler
2 papers
AP
Andrew Paulson
2 papers
BK
Brad Kahl
2 papers
Christina Wu
2 papers
CF
Christos Fountzilas
2 papers
David Bajor
2 papers
Heinz-Josef Lenz
2 papers
Howard Bailey
2 papers
John Strickler
2 papers
JH
Joleen Hubbard
2 papers